0001178913-22-003079.txt : 20220812 0001178913-22-003079.hdr.sgml : 20220812 20220812160540 ACCESSION NUMBER: 0001178913-22-003079 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220812 DATE AS OF CHANGE: 20220812 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CITRON SHIMON CENTRAL INDEX KEY: 0001284150 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24431 FILM NUMBER: 221160020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Artemis Therapeutics, Inc. CENTRAL INDEX KEY: 0001062128 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS CHEMICAL PRODUCTS [2890] IRS NUMBER: 841417774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 18 EAST 16TH STREET CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 646-233-1454 MAIL ADDRESS: STREET 1: 18 EAST 16TH STREET CITY: NEW YORK STATE: NY ZIP: 10003 FORMER COMPANY: FORMER CONFORMED NAME: NEW YORK GLOBAL INNOVATIONS INC. DATE OF NAME CHANGE: 20140305 FORMER COMPANY: FORMER CONFORMED NAME: INKSURE TECHNOLOGIES INC. DATE OF NAME CHANGE: 20050401 FORMER COMPANY: FORMER CONFORMED NAME: INKSURE TECHNOLOGIES INC DATE OF NAME CHANGE: 19980519 3 1 zk2228331.xml X0206 3 2022-06-30 0 0001062128 Artemis Therapeutics, Inc. ATMS 0001284150 CITRON SHIMON 3 ELIEZER VARDINON ST. PETACH TIKVA L3 4959507 ISRAEL 1 1 0 0 Chief Executive Officer Common Stock 15665690 D Common Stock 10443793 I By Spouse Series D Preferred Stock Common Stock 32772000 D Series D Preferred Stock Common Stock 21848400 I By Spouse These securities are beneficially owned by Mr. Citron's spouse, Sigal Citron. Mr. Citron disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Upon the Issuer's increase of its authorized shares of Common Stock, expected in September 2022, all shares of Series D Preferred Stock will automatically convert into the Issuer's Common Stock. The Series D Preferred Stock has no expiration date. Each share of Series D Preferred Stock will convert into 600 shares of the Issuer's Common Stock. /s/ Shimon Citron 2022-08-12